本页面由Tiger Trade Technology Pte. Ltd.提供服务

诺瓦瓦克斯医药

7.98
+0.01000.13%
盘后8.070.0869+1.09%18:54 EDT
成交量:232.34万
成交额:1,836.03万
市值:12.97亿
市盈率:3.09
高:8.04
开:7.80
低:7.71
收:7.97
52周最高:11.97
52周最低:5.01
股本:1.62亿
流通股本:1.37亿
量比:0.57
换手率:1.70%
股息:- -
股息率:- -
每股收益(TTM):2.58
每股收益(LYR):2.58
净资产收益率:-898.20%
总资产收益率:25.72%
市净率:-10.15
市盈率(LYR):3.09

数据加载中...

2020/04/29

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/24

重要事件披露

Current report, items 7.01 and 9.01
2020/03/12

重要事件披露

8-K - Current report
2020/03/11

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/02

重要事件披露

Current report, items 8.01 and 9.01
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/21

重要事件披露

Current report, items 8.01 and 9.01
2020/01/07

SEC问询函

[Cover]Correspondence
2019/11/20

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/08

重要事件披露

Current report, items 2.02 and 9.01
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/09/30

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/30

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/30

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/30

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/18

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/16

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/10

持股变动声明

Statement of changes in beneficial ownership of securities